Want to see ECOR full AI Analyst Report?
ECOR Stock Chart & Stats
$6.50
$0.45(2.64%)
At close: 4:00 PM EST
$6.50
$0.45(2.64%)
Day’s Range― - ―
52-Week Range$4.16 - $10.50
Previous CloseN/A
Volume24.66K
Average Volume (3M)33.66K
Market Cap
$50.02M
Enterprise Value$54.64
Total Cash (Recent Filing)$8.83M
Total Debt (Recent Filing)$9.48M
Price to Earnings (P/E)―
Beta1.86
Next Earnings
Aug 12, 2026EPS Estimate
-0.42Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.81
Shares Outstanding8,295,707
10 Day Avg. Volume29,982
30 Day Avg. Volume33,656
Financial Highlights & Ratios
PEG Ratio-0.72
Price to Book (P/B)-22.29
Price to Sales (P/S)1.19
P/FCF Ratio-4.62
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$16.62Price Target Upside155.64% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)-1.5
Revenue Forecast (FY)$41.92M
Bulls Say, Bears Say
Bulls Say
Revenue Scaling With High Gross MarginsSustained top-line growth alongside very high gross margins indicates strong unit economics and pricing power for gammaCore. Durable revenue scale reduces reliance on one-off sales, gives room for operating leverage, and supports a realistic pathway to profitability as fixed costs are absorbed.
VA And Federal Channel TractionIncreasing VA penetration and federal adoption create a durable, reimbursement-backed revenue stream. Federal channels often yield stable demand and favorable coverage; deeper VA/DoD presence plus experienced commercial leadership strengthens long-term payor access and scale prospects.
High Margins And Improving Adjusted EBITDAMid‑80s gross margins and narrowing adjusted EBITDA losses demonstrate sustainable unit profitability and operating leverage. If management sustains revenue growth, margin profile supports converting operating leverage into positive EBITDA and eventually GAAP profitability over the medium term.
Bears Say
Weakened Balance Sheet; Negative EquityNegative equity and shrinking assets materially reduce financial flexibility and increase refinancing and dilution risk. A weakened capital structure limits ability to absorb shocks, constrains strategic optionality, and elevates the cost or scarcity of external capital needed to fund growth.
Persistent Negative Free Cash FlowConsistent negative operating and free cash flow means the business relies on external financing to run and scale. That dependency raises liquidity risk if markets tighten, restricts reinvestment capacity, and can force dilution or debt issuance that hampers long-term strategic execution.
Ongoing Operating Losses And Elevated SG&ADespite revenue growth, persistent operating losses and high SG&A limit free cash generation and delay sustainable profitability. Elevated commercial and legal costs can persist, making the profitability inflection dependent on continued top-line momentum and disciplined expense control.
Electrocore News
ECOR FAQ
What was Electrocore Llc’s price range in the past 12 months?
Electrocore Llc lowest stock price was $4.16 and its highest was $10.49 in the past 12 months.
What is Electrocore Llc’s market cap?
Electrocore Llc’s market cap is $50.02M.
When is Electrocore Llc’s upcoming earnings report date?
Electrocore Llc’s upcoming earnings report date is Aug 12, 2026 which is in 26 days.
How were Electrocore Llc’s earnings last quarter?
Electrocore Llc released its earnings results on May 06, 2026. The company reported -$0.59 earnings per share for the quarter, beating the consensus estimate of -$0.612 by $0.022.
Is Electrocore Llc overvalued?
According to Wall Street analysts Electrocore Llc’s price is currently Undervalued.
Does Electrocore Llc pay dividends?
Electrocore Llc does not currently pay dividends.
What is Electrocore Llc’s EPS estimate?
Electrocore Llc’s EPS estimate is -0.42.
How many shares outstanding does Electrocore Llc have?
Electrocore Llc has 8,295,707 shares outstanding.
What happened to Electrocore Llc’s price movement after its last earnings report?
Electrocore Llc reported an EPS of -$0.59 in its last earnings report, beating expectations of -$0.612. Following the earnings report the stock price went down -5.856%.
Which hedge fund is a major shareholder of Electrocore Llc?
Currently, no hedge funds are holding shares in ECOR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Electrocore Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$16.62 (155.64% Upside)
$16.62 (155.64% Upside)
Insider Transactions
Sold Shares
Worth $563.7K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-61.72%
12-Months-Change
Fundamentals
Return on Equity
836.32%
Trailing 12-Months
Asset Growth
-3.48%
Trailing 12-Months
Company Description
Electrocore Llc
electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches. Its flagship offering, the gammaCore Sapphire, is a portable, rechargeable, and refillable device intended for either regular or intermittent use over many years. Established in 2005, its corporate headquarters are situated in Rockaway, New Jersey.
ECOR Stock 12 Month Forecast
Average Price Target
$16.62
▲(155.64% Upside)
Technical Analysis
Myomo
―
Modular Medical
―
NeuroOne Medical Technologies
―
Vivos Therapeutics
―
Adagio Medical Holdings
―
Ownership Overview
13.80% Insiders
3.15% Mutual Funds
<0.01% Other Institutional Investors
80.31% Public Companies and
Individual Investors